Knowledge (XXG)

Hereditary nonpolyposis colorectal cancer

Source đź“ť

843:(MMR) protein expression in tumours that are associated with Lynch syndrome. While it is not diagnostic of a Lynch syndrome, it can play a role in identifying people who should have germline testing. Two methods of implementation of IHC testing includes age-based testing and universal testing for all people. Currently, there is no widespread agreement regarding which screening method should be used. Age-based testing for IHC has been suggested in part due to cost-benefit analyses, whereas universal testing for all people with colorectal cancer ensures people with Lynch Syndrome are not missed. To address the costs, researchers are trying to predict MSI or IHC directly from the way the tumor looks under the microscope, without doing any molecular testing. 43: 86: 512: 792:. Therefore, families found to have a deleterious mutation in a Lynch syndrome gene should be considered to have Lynch syndrome regardless of the extent of the family history. This also means that the Amsterdam criteria fail to identify many people who are at risk for Lynch syndrome. Improving the criteria for screening is an active area of research, as detailed in the Screening Strategies section of this article. 796:
new generation, without inheriting the gene. These people are often only identified after developing an early-life colon cancer. Parents with HNPCC have a 50% chance of passing the genetic mutation on to each child. It is also important to note, that deleterious mutation in one of MMR genes alone is not sufficient to cause cancer, but that rather further mutations in other tumour suppressor genes need to occur.
1212:, characterized the syndrome in 1966. In his earlier work, he described the disease entity as "cancer family syndrome." The term "Lynch syndrome" was coined in 1984 by other authors; Lynch named the condition HNPCC in 1985. Since then the two terms have been used interchangeably, until later advances in the understanding of the genetics of the disease led to the term HNPCC falling out of favor. 795:
Most people with Lynch syndrome inherit the condition from a parent. However, due to incomplete penetrance, variable age of cancer diagnosis, cancer risk reduction, or early death, not all people with an Lynch syndrome gene mutation have a parent who had cancer. Some people develop HNPCC de-novo in a
1223:
are met but there is no known DNA mismatch repair defect. The putative "type X" families appear to have a lower overall incidence of cancer and lower risk for non-colorectal cancers than families with documented DNA mismatch repair deficiency. About 35% of people who meet Amsterdam criteria do not
1066:
The Bethesda criteria were developed in 1997 and later updated in 2004 by the National Cancer Institute to identify persons requiring further testing for Lynch syndrome through MSI. In contrast to the Amsterdam Criteria, the Revised Bethesda Guidelines use pathological data in addition to clinical
585:
The impairment of either gene for the protein dimer impairs the protein function. These 4 genes are involved in error correction (mismatch repair), so dysfunction of the genes can lead to the inability to fix DNA replication errors and cause Lynch syndrome. Lynch syndrome is known to be associated
784:
mutations are more likely to be Amsterdam criteria II-negative. The presentation with MSH6 is slightly different from with MLH1 and MSH2, and the term "MSH6 syndrome" has been used to describe this condition. In one study, the Bethesda guidelines were more sensitive than the Amsterdam Criteria in
3165:
Stjepanovic N, Moreira L, Carneiro F, Balaguer F, Cervantes A, Balmaña J, Martinelli E; ESMO Guidelines Committee. Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow- up†. Ann Oncol. 2019 Oct 1;30(10):1558-1571. doi: 10.1093/annonc/mdz233.
1197:. Lynch syndrome-causing mutations are found in approximately 3% of all diagnosed colorectal cancers, and 1.8% of all diagnosed endometrial cancers. The average age of diagnosis of cancer in patients with this syndrome is 44 years old, as compared to 64 years old in people without the syndrome. 3282:
André, Thierry; Shiu, Kai-Keen; Kim, Tae Won; Jensen, Benny Vittrup; Jensen, Lars Henrik; Punt, Cornelis; Smith, Denis; Garcia-Carbonero, Rocio; Benavides, Manuel; Gibbs, Peter; de la Fouchardiere, Christelle; Rivera, Fernando; Elez, Elena; Bendell, Johanna; Le, Dung T.; Yoshino, Takayuki; Van
1180:
Though the exact prevalence of Lynch syndrome-causing mutations in the general population remain unknown, recent studies estimate the prevalence to be 1 in 279 individuals, or 0.35%. Certain populations are known to have a higher prevalence of founder mutations, including, but not limited to,
946:
are recommended as a preventative method of surveillance for individuals who have Lynch syndrome, or LS-associated genes. Specifically, it is recommended that colonoscopies begin at ages 20–25 for MLH1 and MSH2 mutation carriers and 35 years for MSH6 and PMS2 mutation carriers. Colonoscopic
828:(MSI) testing. In the US, professional societies recommend testing every colon cancer for MSI or IHC as screening for Lynch syndrome, but this is not always performed because of cost and resource limitations. Genetic testing is commercially available and consists of a blood test. 1140:
or total colectomy with ileorectal anastomosis. Due to increased risk of colorectal cancer following partial colectomy and similar quality of life after both surgeries, a total colectomy may be a preferred treatment for Lynch syndrome, especially in younger patients.
963:
is recommended annually for ovarian and endometrial cancer screening. For women with Lynch syndrome, a yearly CA-125 blood test can be used to screen for ovarian cancer, however there is limited data on the efficacy of this test in reducing mortality.
2404:
Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW, et al. (August 2014). "Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on colorectal cancer".
4009: 3990: 286:
diagnosis is 44 for members of families that meet the Amsterdam criteria. The average age of diagnosis of endometrial cancer is about 46 years. Among women with HNPCC who have both colon and endometrial cancer, about half present first with
1504:
Sobocińska, Joanna; Kolenda, Tomasz; Teresiak, Anna; Badziąg-Leśniak, Natalia; Kopczyńska, Magda; Guglas, Kacper; Przybyła, Anna; Filas, Violetta; Bogajewska-Ryłko, Elżbieta; Lamperska, Katarzyna; Mackiewicz, Andrzej (2020-10-05).
972:
There are also strategies for detecting other cancers early or reducing the chances of developing them that people with Lynch syndrome can discuss with their doctor, however their effectiveness is not clear. These options include:
295:
is 56 years of age with intestinal-type adenocarcinoma being the most commonly reported pathology. HNPCC-associated ovarian cancers have an average age of diagnosis of 42.5 years-old; approximately 30% are diagnosed before age 40.
2785:"Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG)" 1082:
Presence of synchronous or metachronous colorectal or other Lynch syndrome associated cancers (e.g. cancers of endometrium, ovary, stomach, small bowel, pancreas, biliary tract, ureter, renal pelvis, brain, sebaceous glands,
4737: 2245:
Ramsoekh D, Wagner A, van Leerdam ME, Dinjens WN, Steyerberg EW, Halley DJ, et al. (November 2008). "A high incidence of MSH6 mutations in Amsterdam criteria II-negative families tested in a diagnostic setting".
872:, suggesting that tumor-infiltrating lymphocytes might be a good option for therapy for these patients. High numbers of tumor-infiltrating lymphocytes were related with better survival rates and treatment responses. 867:
analysis of microsatellite regions. MSI analysis can be used to identify people who may have Lynch syndrome and direct them for further testing. One study noted that one third of MSI colorectal cancers showed a low
2383: 1564:
Møller, Pål; Seppälä, Toni T.; Bernstein, Inge; Holinski-Feder, Elke; Sala, Paulo; Gareth Evans, D.; Lindblom, Annika; Macrae, Finlay; Blanco, Ignacio; Sijmons, Rolf H.; Jeffries, Jacqueline (2018).
2966:
Vasen, Hans F A; Blanco, Ignacio; Aktan-Collan, Katja; Gopie, Jessica P; Alonso, Angel; Aretz, Stefan; Bernstein, Inge; Bertario, Lucio; Burn, John; Capella, Gabriel; Colas, Chrystelle (June 2013).
4730: 291:, making endometrial cancer the most common sentinel cancer in Lynch syndrome. The most common symptom of endometrial cancer is abnormal vaginal bleeding. In HNPCC, the mean age of diagnosis of 299:
Significant variation in the rate of cancer has been found depending on the mutation involved. Up to the age of 75 years the risks of different cancers by the mutations are in the table below.
1398:
Vogel JD, Eskicioglu C, Weiser MR, Feingold DL, Steele SR (October 2017). "The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Treatment of Colon Cancer".
2045:
Miyaki M, Konishi M, Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Yasuno M, et al. (November 1997). "Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer".
859:). MSI is associated with alternate sized repetitive DNA sequences that are not present in the correlated germ line DNA resulting in 15-20% of colorectal cancers. MSI is identified through 4983: 5003: 4723: 1100:
It is important to note that these clinical criteria can be difficult to use in practice and clinical criteria used alone misses between 12 and 68 percent of Lynch syndrome cases.
1839:
Tamura K, Kaneda M, Futagawa M, Takeshita M, Kim S, Nakama M, et al. (September 2019). "Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome".
4174: 2091:
Nicolaides NC, Papadopoulos N, Liu B, Wei YF, Carter KC, Ruben SM, et al. (September 1994). "Mutations of two PMS homologues in hereditary nonpolyposis colon cancer".
2142:
Lu SL, Kawabata M, Imamura T, Akiyama Y, Nomizu T, Miyazono K, Yuasa Y (May 1998). "HNPCC associated with germline mutation in the TGF-beta type II receptor gene".
851:
Mutations in DNA mismatch repair systems can lead to difficulty transmitting regions within the DNA which contain repeating patterns of two or three nucleotides (
3826:"Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic" 1096:
Person with colorectal cancer and two or more first- or second-degree relatives with colorectal cancer or Lynch syndrome associated cancer diagnosed at any age.
1093:
Colorectal cancer diagnosed in a person with one or more first-degree relative with colorectal cancer or Lynch syndrome associated tumour diagnosed under age 50
2340:
Goldberg Y, Porat RM, Kedar I, Shochat C, Galinsky D, Hamburger T, et al. (June 2010). "An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC".
1016:
Amsterdam I Criteria (all bullet points must be fulfilled): The Amsterdam I criteria were published in 1990; however, were felt to be insufficiently sensitive.
243:
In addition to the types of cancer found in the chart above, it is understood that Lynch syndrome also contributes to an increased risk of small bowel cancer,
1021:
Three or more family members with a confirmed diagnosis of colorectal cancer, one of whom is a first degree (parent, child, sibling) relative of the other two
4405: 2387: 161: 1136:
Surgery remains the front-line therapy for Lynch syndrome. Patients with Lynch syndrome who develop colorectal cancer may be treated with either a partial
3489: 2002:
Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, et al. (March 1994). "Mutation of a mutL homolog in hereditary colon cancer".
3025:"New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC" 4113: 3186:"The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside" 2447:"Artificial Intelligence for Histology-Based Detection of Microsatellite Instability and Prediction of Response to Immunotherapy in Colorectal Cancer" 1755:"Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review" 4167: 4655: 3689:"Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds" 4515: 3357: 2566: 2510: 1714:"Mutated gene-specific phenotypes of dinucleotide repeat instability in human colorectal carcinoma cell lines deficient in DNA mismatch repair" 1566:"Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database" 1164:
In 2024 development for a vaccine called LynchVax that would reduce the risk of cancer from the disease has been started by scientist from the
1156:
Checkpoint blockade with anti-PD-1 therapy is now preferred first line therapy for advanced Microsatellite-Instability–High colorectal cancer.
3949: 3511:
Lynch HT, Shaw MW, Magnuson CW, Larsen AL, Krush AJ (February 1966). "Hereditary factors in cancer. Study of two large midwestern kindreds".
3738:"Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instability" 3737: 562:
MLH1 protein dimerizes with PMS2 protein to form MutLα, which coordinates the binding of other proteins involved with mismatch repair like
4704: 4660: 4160: 4028: 1209: 1037:
The Amsterdam II criteria were developed in 1999 and improved the diagnostic sensitivity for Lynch syndrome by including cancers of the
2835:
Ring KL, Garcia C, Thomas MH, Modesitt SC (November 2017). "Current and future role of genetic screening in gynecologic malignancies".
1446: 4778: 3825: 1963:"Lynch Syndrome and Muir-Torre Syndrome: An update and review on the genetics, epidemiology, and management of two related disorders" 1696: 1434: 4267: 813: 634: 461: 4832: 4958: 4563: 3073:
Vindigni SM, Kaz AM (April 2016). "Universal Screening of Colorectal Cancers for Lynch Syndrome: Challenges and Opportunities".
935:
and genetic testing are recommended for families that meet the Amsterdam criteria, preferably before the onset of colon cancer.
816:
gene, identified by genetic testing. Candidates for germline genetic testing can be identified by clinical criteria such as the
4881: 3640:"Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X" 567: 42: 4998: 4754: 4665: 4468: 4425: 4396: 1059: 1030: 54: 4937: 4376: 3777:"Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability" 4137: 3546:
Bellizzi AM, Frankel WL (November 2009). "Colorectal cancer due to deficiency in DNA mismatch repair function: a review".
2968:"Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts" 4715: 4694: 4368: 4281: 4191: 4121: 1236: 996: 4993: 4746: 4634: 4410: 4386: 1694:
Pathology of Hereditary Nonpolyposis Colorectal Cancer - JASS 910 (1): 62 - Annals of the New York Academy of Sciences
1507:"Diagnostics of Mutations in MMR/EPCAM Genes and Their Role in the Treatment and Care of Patients with Lynch Syndrome" 1239:, AliveAndKickn, Lynch Syndrome UK and Bowel Cancer UK. In the US, National Lynch Syndrome Awareness Day is March 22. 4372: 2187:"Biochemical characterization of MLH3 missense mutations does not reveal an apparent role of MLH3 in Lynch syndrome" 1926:
Yurgelun MB, Hampel H (May 2018). "Recent Advances in Lynch Syndrome: Diagnosis, Treatment, and Cancer Prevention".
4988: 4904: 4859: 4820: 4650: 4391: 4245: 2562:"Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation" 898: 881: 856: 825: 532: 62: 4899: 4147: 2719:
Taieb, Julien; Svrcek, Magali; Cohen, Romain; Basile, Debora; Tougeron, David; Phelip, Jean-Marc (November 2022).
4558: 4487: 4183: 864: 4953: 1148:-based adjuvant therapies for Lynch syndrome-related colorectal tumours, particularly those in stages I and II. 1050:
Three or more family members with HNPCC-related cancers, one of whom is a first-degree relative of the other two
4510: 4364: 4141: 4045: 3888: 4876: 2936: 2878:
Sroczynski G, Gogollari A, Conrads-Frank A, Hallsson LR, Pashayan N, Widschwendter M, Siebert U (July 2020).
2618:"Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer" 1928:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
4699: 4448: 4217: 2880:"Cost-Effectiveness of Early Detection and Prevention Strategies for Endometrial Cancer-A Systematic Review" 1227:
Complicating matters is the presence of an alternative set of criteria, known as the "Bethesda Guidelines."
1012:
The following are the Amsterdam criteria in identifying high-risk candidates for molecular genetic testing:
956: 130: 4799: 4540: 4328: 4290: 4200: 4126: 4110: 982: 3283:
Cutsem, Eric; Yang, Ping; Farooqui, Mohammed Z.H.; Marinello, Patricia; Diaz, Luis A. (3 December 2020).
2721:"Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment" 4842: 4096: 3590: 1113: 4400: 4132: 3687:
Scott RJ, McPhillips M, Meldrum CJ, Fitzgerald PE, Adams K, Spigelman AD, et al. (January 2001).
2445:
Hildebrand, Lindsey A.; Pierce, Colin J.; Dennis, Michael; Paracha, Munizay; Maoz, Asaf (2021-01-21).
2214: 511: 4545: 3824:
Lipton LR, Johnson V, Cummings C, Fisher S, Risby P, Eftekhar Sadat AT, et al. (December 2004).
3775:
Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, RĂĽschoff J, et al. (February 2004).
2100: 2011: 1804:
Peltomäki P (March 2003). "Role of DNA mismatch repair defects in the pathogenesis of human cancer".
1165: 836: 821: 544: 263:
has also been associated with Lynch syndrome, although this relationship is not entirely understood.
248: 58: 17: 3591:"Familial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndrome" 1261:"Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer" 4941: 4863: 4013: 1887:"The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer" 1753:
Yokoyama T, Takehara K, Sugimoto N, Kaneko K, Fujimoto E, Okazawa-Sakai M, et al. (May 2018).
1216: 1128:
to prevent cancer from developing) can be performed before ovarian or endometrial cancer develops.
921: 840: 809: 591: 528: 252: 150: 85: 2186: 4605: 4587: 4527: 4356: 4352: 3571: 3314: 3148: 3098: 2860: 2750: 2560:
Snowsill T, Coelho H, Huxley N, Jones-Hughes T, Briscoe S, Frayling IM, Hyde C (September 2017).
2504:
Snowsill T, Huxley N, Hoyle M, Jones-Hughes T, Coelho H, Cooper C, et al. (September 2014).
2365: 2271: 2227: 2167: 2124: 2070: 1864: 1658: 1220: 1169: 960: 932: 817: 789: 524: 516: 288: 134: 118: 114: 3853: 4828: 4672: 4624: 4615: 4338: 4240: 4209: 4056: 3955: 3945: 3845: 3806: 3757: 3718: 3669: 3620: 3563: 3528: 3471: 3417: 3306: 3264: 3215: 3167: 3140: 3123:
Bui QM, Lin D, Ho W (February 2017). "Approach to Lynch Syndrome for the Gastroenterologist".
3090: 3046: 3005: 2987: 2911: 2852: 2814: 2742: 2701: 2649: 2593: 2537: 2486: 2468: 2422: 2357: 2322: 2263: 2219: 2159: 2116: 2062: 2027: 1984: 1943: 1908: 1856: 1821: 1786: 1735: 1650: 1642: 1603: 1585: 1546: 1528: 1486: 1442: 1415: 1349: 1300: 1282: 1190: 1075:
If a person meets any 1 of 5 criteria the tumour(s) from the person should be tested for MSI:
805: 555: 283: 244: 74: 1885:
Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, et al. (December 1993).
985:
cancer every 3–5 years, starting at age 30 at the earliest (preferably in a research setting)
4473: 4347: 4262: 4250: 3837: 3796: 3788: 3749: 3708: 3700: 3659: 3651: 3610: 3602: 3555: 3520: 3461: 3453: 3407: 3399: 3296: 3254: 3246: 3205: 3197: 3132: 3082: 3036: 2995: 2979: 2901: 2891: 2844: 2804: 2796: 2783:
Monahan KJ, Bradshaw N, Dolwani S, Desouza B, Dunlop MG, East JE, et al. (March 2020).
2732: 2691: 2683: 2639: 2629: 2583: 2575: 2527: 2519: 2476: 2458: 2414: 2349: 2312: 2302: 2255: 2209: 2201: 2151: 2108: 2054: 2019: 1974: 1935: 1898: 1848: 1813: 1776: 1766: 1725: 1634: 1593: 1577: 1536: 1518: 1407: 1339: 1331: 1318:
Kastrinos F, Mukherjee B, Tayob N, Wang F, Sparr J, Raymond VM, et al. (October 2009).
1290: 1272: 1235:
There are a number of non-profit organisations providing information and support, including
1182: 4932: 4762: 4750: 4315: 4298: 4117: 1700: 1693: 1452: 1084: 947:
surveillance should then be performed at a 1-2 year interval for Lynch Syndrome patients.
894: 326: 267: 256: 154: 2668: 2506:"A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome" 1090:
Colorectal cancer with MSI-high pathology in a person who is younger than 60 years of age
909:
but researchers are trying to use artificial intelligence to predict MSI from histology.
149:. The increased risk for these cancers is due to inherited genetic mutations that impair 3909: 2767: 2185:
Ou J, Rasmussen M, Westers H, Andersen SD, Jager PO, Kooi KA, et al. (April 2009).
2104: 2015: 4948: 4927: 4849: 4629: 4592: 4522: 4420: 4360: 4303: 4232: 4222: 3801: 3776: 3713: 3688: 3664: 3639: 3615: 3466: 3441: 3412: 3387: 3259: 3234: 3233:
Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H, Eyring AD, et al. (June 2015).
3210: 3185: 3000: 2967: 2906: 2879: 2809: 2784: 2696: 2644: 2617: 2588: 2532: 2481: 2446: 2317: 2290: 1781: 1754: 1598: 1565: 1541: 1506: 1344: 1319: 1295: 1260: 1205: 1194: 1145: 1121: 989: 978: 860: 852: 571: 314: 292: 126: 122: 27:
Autosomal dominant genetic condition associated with a high risk of cancer in the colon
4022: 4018: 3041: 3024: 4977: 4921: 4837: 4573: 4255: 3638:
Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, et al. (April 2005).
3318: 2754: 1903: 1886: 1868: 943: 260: 138: 3575: 3152: 2864: 2369: 2275: 2231: 2171: 2074: 1961:
Le S, Ansari U, Mumtaz A, Malik K, Patel P, Doyle A, Khachemoune A (November 2017).
1662: 4535: 3736:
Gologan A, Krasinskas A, Hunt J, Thull DL, Farkas L, Sepulveda AR (November 2005).
3102: 2128: 1676: 1372: 1109: 554:
The 4 main genes involved in Lynch syndrome normally encode for proteins that form
275: 103: 3388:"Recent progress in Lynch syndrome and other familial colorectal cancer syndromes" 66: 4050: 3753: 3559: 3332: 2770:. From Medscape. By Juan Carlos Munoz and Louis R Lambiase. Updated: Oct 31, 2011 2418: 1411: 4891: 4600: 4553: 4496: 4440: 4080: 1621:
Ring, Kari L.; Garcia, Christine; Thomas, Martha H.; Modesitt, Susan C. (2017).
1523: 1038: 1000: 869: 320:
upper gastrointestinal (gastric, duodenal, bile duct or pancreatic) cancer risk
279: 146: 142: 3524: 3457: 2983: 2848: 2800: 2737: 2720: 1852: 1638: 1581: 1474: 4811: 4788: 4686: 4085: 4061: 3959: 3606: 3201: 3136: 3086: 2353: 2307: 1771: 1186: 788:
Up to 39% of families with mutations in a Lynch syndrome gene do not meet the
548: 50: 4152: 3655: 3285:"Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer" 2991: 2472: 1646: 1589: 1532: 1286: 1277: 179:
Lifetime risk and mean age at diagnosis for Lynch syndrome–associated cancers
4582: 4505: 4323: 4148:
National Cancer Institute: Genetics of Colorectal Cancer information summary
4003: 3999: 3841: 2896: 2634: 2616:
Evrard C, Tachon G, Randrian V, Karayan-Tapon L, Tougeron D (October 2019).
2463: 2259: 2023: 1817: 1137: 906: 578: 577:
MSH2 protein dimerizes with MSH6 protein, which identifies mismatches via a
540: 3849: 3810: 3761: 3722: 3673: 3624: 3567: 3475: 3421: 3310: 3268: 3219: 3171: 3144: 3094: 3050: 3009: 2915: 2856: 2818: 2746: 2705: 2687: 2653: 2597: 2541: 2490: 2426: 2361: 2326: 2267: 2223: 1988: 1947: 1860: 1825: 1790: 1739: 1730: 1713: 1654: 1622: 1607: 1550: 1490: 1419: 1353: 1335: 1304: 905:
The histopathological criteria are not sensitive enough to detect MSI from
3792: 3532: 3301: 3284: 3250: 2163: 2120: 2066: 2031: 1912: 1623:"Current and future role of genetic screening in gynecologic malignancies" 4793: 4772: 4645: 4091: 1979: 1962: 1067:
information to help health care providers identify persons at high risk.
563: 271: 79: 2667:
Nouri Nojadeh, Jafar; Behrouz Sharif, Shahin; Sakhinia, Ebrahim (2018).
1939: 3403: 2058: 992:, starting at age 30 at the earliest (preferably in a research setting) 863:
from both a tumor tissue sample and a normal tissue sample followed by
117:
genetic condition that is associated with a high risk of colon cancer,
3982: 2205: 2155: 1880: 1878: 1219:
defect, and use the term "familial colorectal cancer type X" when the
1215:
Other sources reserve the term "Lynch syndrome" when there is a known
920:(HNPCC associated with other cancers of the gastrointestinal tract or 3994: 3867: 2579: 2561: 2523: 2505: 2112: 1117: 1056:
One or more of the HNPCC-related cancers diagnosed under age 50 years
743: 536: 3942:
Daughter of Family G. : a memoir of cancer genes, love and fate
3704: 1125: 510: 531:, which causes an elevated rate of single nucleotide changes and 4642: 4039: 4036: 4033: 3358:"Work starts on a cancer vaccine for people with Lynch syndrome" 884:– MSI) cancers can be recognized by histopathological criteria: 763: 722: 701: 680: 659: 652: 628: 621: 600: 587: 535:, also known as MSI-H (the H is "high"). MSI is identifiable in 491: 476: 455: 440: 4719: 4156: 3497: 1045:
Amsterdam Criteria II (all bullet points must be fulfilled):
3910:"CDC: March 22nd is National Lynch Syndrome Awareness Day!" 2384:"Fact Sheet 33 | BOWEL CANCER AND INHERITED PREDISPOSITION" 1320:"Risk of pancreatic cancer in families with Lynch syndrome" 543:
laboratory. Most cases result in changes in the lengths of
804:
A diagnosis of Lynch syndrome is applied to people with a
270:
and common signs and symptoms include blood in the stool,
3333:"Lynchvax: Vaccine hope for cancer risk genetic disorder" 3235:"PD-1 Blockade in Tumors with Mismatch-Repair Deficiency" 3023:
Vasen HF, Watson P, Mecklin JP, Lynch HT (June 1999).
1172:
but clinical trials are far from being conducted yet.
1027:
One or more colon cancers diagnosed under age 50 years
839:(IHC) is a method that can be used to detect abnormal 820:
and Bethesda Guidelines, or through tumor analysis by
1473:
Braun MM, Overbeek-Wager EA, Grumbo RJ (March 2016).
527:
fashion. The hallmark of Lynch syndrome is defective
3972: 1144:
There is an ongoing controversy over the benefit of
160:
Other HNPCC conditions include Lynch-like syndrome,
4913: 4890: 4858: 4819: 4810: 4761: 4685: 4614: 4572: 4495: 4486: 4461: 4439: 4337: 4314: 4289: 4280: 4231: 4208: 4199: 4190: 4071: 3976: 1712:Oki E, Oda S, Maehara Y, Sugimachi K (March 1999). 1003:
or spinal cord), starting at age 25 at the earliest
73: 35: 1259:Carethers, John M; Stoffel, Elena M (2015-08-21). 855:), otherwise known as microsatellite instability ( 3184:Boland CR, Koi M, Chang DK, Carethers JM (2007). 2669:"Microsatellite instability in colorectal cancer" 995:Annual physical and neurological exams to detect 1475:"Diagnosis and Management of Endometrial Cancer" 897:in any location showing any measurable level of 551:cytosine and adenine (sequence: CACACACACA...). 4984:DNA replication and repair-deficiency disorders 4127:GeneReviews/NCBI/NIH/UW entry on Lynch syndrome 3742:Archives of Pathology & Laboratory Medicine 3440:Biller LH, Syngal S, Yurgelun MB (April 2019). 1441:(2nd ed.). New York: McGraw-Hill Medical. 5004:Syndromes affecting the gastrointestinal tract 3386:Boland PM, Yurgelun MB, Boland CR (May 2018). 2086: 2084: 109:HNPCC includes (and was once synonymous with) 65:-H tumours, as may be seen in Lynch syndrome. 4731: 4168: 2837:American Journal of Obstetrics and Gynecology 2440: 2438: 2436: 1627:American Journal of Obstetrics and Gynecology 423:Risk of gynecologic cancer in Lynch syndrome 8: 1152:Anti-PD-1 antibody therapy can be effective. 162:polymerase proofreading-associated polyposis 4816: 4738: 4724: 4716: 4492: 4286: 4205: 4196: 4175: 4161: 4153: 3973: 3964:Paperback version retitled Before My Time. 3595:Surgical Oncology Clinics of North America 2215:11370/b74f7d2b-12fb-4bfc-a8c8-2d8950e81972 1841:International Journal of Clinical Oncology 1224:have a DNA-mismatch-repair gene mutation. 812:genes (MLH1, MSH2, MSH6, and PMS2) or the 421: 84: 41: 32: 4872:Hereditary nonpolyposis colorectal cancer 4431:Hereditary nonpolyposis colorectal cancer 3800: 3712: 3663: 3614: 3465: 3411: 3300: 3258: 3209: 3040: 2999: 2905: 2895: 2808: 2736: 2695: 2643: 2633: 2587: 2531: 2480: 2462: 2316: 2306: 2213: 1978: 1902: 1780: 1770: 1729: 1597: 1540: 1522: 1343: 1294: 1276: 1079:Colorectal cancer diagnosed before age 50 888:right-sided poorly differentiated cancers 609:Frequency of mutations in HNPCC families 266:Two-thirds of colon cancers occur in the 96:Hereditary nonpolyposis colorectal cancer 36:Hereditary nonpolyposis colorectal cancer 3781:Journal of the National Cancer Institute 1041:, small bowel, ureter and renal pelvis. 596: 301: 183: 4656:Intraductal papillary mucinous neoplasm 2768:Hereditary Colorectal Cancer Background 1248: 912:In addition, HNPCC can be divided into 164:and familial colorectal cancer type X. 2611: 2609: 2607: 2295:Hereditary Cancer in Clinical Practice 3435: 3433: 3431: 3381: 3379: 3377: 3118: 3116: 3114: 3112: 3068: 3066: 3064: 3062: 3060: 2961: 2959: 2957: 2931: 2929: 2927: 2925: 2830: 2828: 2778: 2776: 2555: 2553: 2551: 2399: 2397: 1367: 1365: 1363: 1254: 1252: 18:Hereditary non-polyposis colon cancer 7: 997:cancer in the central nervous system 581:, a protein for scanning for errors. 102:) is a hereditary predisposition to 4705:Desmoplastic small round cell tumor 3944:. Toronto: Alfred A. Knopf Canada. 3442:"Recent advances in Lynch syndrome" 3392:CA: A Cancer Journal for Clinicians 3239:The New England Journal of Medicine 1210:Creighton University Medical Center 1053:Two successive affected generations 1024:Two successive affected generations 568:single-stranded-DNA binding-protein 4406:Polymerase proofreading-associated 3693:American Journal of Human Genetics 523:Lynch syndrome is inherited in an 25: 4268:Hereditary diffuse gastric cancer 3889:"Bowel Cancer UK: Lynch Syndrome" 2289:Suchy J, Lubinski J (June 2008). 1265:World Journal of Gastroenterology 4959:Severe combined immunodeficiency 4564:Nodular regenerative hyperplasia 3362:Cancer Research UK - Cancer News 1435:"Chapter 33: Endometrial Cancer" 1400:Diseases of the Colon and Rectum 4882:Mismatch repair cancer syndrome 3289:New England Journal of Medicine 3125:Digestive Diseases and Sciences 3075:Digestive Diseases and Sciences 2194:Genes, Chromosomes & Cancer 4755:DNA repair-deficiency disorder 4666:Solid pseudopapillary neoplasm 4469:Gastrointestinal stromal tumor 4426:Familial adenomatous polyposis 3548:Advances in Anatomic Pathology 1060:Familial adenomatous polyposis 1031:Familial adenomatous polyposis 247:, ureter/renal pelvis cancer, 193:Mean age at diagnosis (years) 55:tumor-infiltrating lymphocytes 1: 4474:Krukenberg tumor (metastatic) 3513:Archives of Internal Medicine 3042:10.1016/S0016-5085(99)70510-X 880:Three major groups of MSI-H ( 61:), a finding associated with 4833:DeSanctis–Cacchione syndrome 4779:Aicardi–Goutières syndrome 4 4695:Primary peritoneal carcinoma 4369:traditional serrated adenoma 4122:National Institute of Health 3830:Journal of Clinical Oncology 3754:10.5858/2005-129-1390-POTRBG 3560:10.1097/PAP.0b013e3181bb6bdc 2567:Health Technology Assessment 2511:Health Technology Assessment 2419:10.1053/j.gastro.2014.04.001 1904:10.1016/0092-8674(93)90546-3 1806:Journal of Clinical Oncology 1412:10.1097/DCR.0000000000000926 1237:Lynch Syndrome International 988:Annual urinalysis to detect 977:Upper endoscopies to detect 916:(familial colon cancer) and 891:right-sided mucinous cancers 4635:Pancreatic ductal carcinoma 1524:10.3390/diagnostics10100786 1208:, Professor of Medicine at 1071:Revised Bethesda Guidelines 818:Amsterdam Clinical Criteria 323:urinary tract cancers risk 5020: 4905:Nijmegen breakage syndrome 4821:Nucleotide excision repair 4651:Serous microcystic adenoma 4246:Signet ring cell carcinoma 4184:Digestive system neoplasia 3589:Lindor NM (October 2009). 3525:10.1001/archinte.117.2.206 3458:10.1007/s10689-018-00117-1 2984:10.1136/gutjnl-2012-304356 2849:10.1016/j.ajog.2017.04.011 2801:10.1136/gutjnl-2019-319915 2738:10.1016/j.ejca.2022.07.020 2725:European Journal of Cancer 1967:Dermatology Online Journal 1853:10.1007/s10147-019-01494-y 1639:10.1016/j.ajog.2017.04.011 1582:10.1136/gutjnl-2017-314057 951:Endometrial/ovarian cancer 899:intraepithelial lymphocyte 882:microsatellite instability 847:Microsatellite instability 826:microsatellite instability 606:Genes implicated in HNPCC 533:microsatellite instability 4938:Rothmund–Thomson syndrome 4559:Focal nodular hyperplasia 3607:10.1016/j.soc.2009.07.003 3202:10.1007/s10689-007-9145-9 3137:10.1007/s10620-016-4346-4 3087:10.1007/s10620-015-3964-6 2354:10.1007/s10689-009-9298-9 2308:10.1186/1897-4287-6-2-103 1772:10.1186/s12885-018-4489-0 1479:American Family Physician 515:HNPCC is inherited in an 49: 40: 4661:Mucinous cystic neoplasm 4511:Hepatocellular carcinoma 4365:sessile serrated adenoma 3656:10.1001/jama.293.16.1979 3356:Gunn, Tim (2024-09-09). 1278:10.3748/wjg.v21.i31.9253 586:with other mutations in 434:Endometrial cancer risk 311:endometrial cancer risk 4770:Separation/initiation: 4700:Peritoneal mesothelioma 4449:Squamous cell carcinoma 4218:Squamous cell carcinoma 3842:10.1200/JCO.2004.11.084 2937:"Medical Options | CDC" 2897:10.3390/cancers12071874 2635:10.3390/cancers11101567 2464:10.3390/cancers13030391 2260:10.1136/gut.2008.156695 2024:10.1126/science.8128251 1818:10.1200/JCO.2003.04.060 1681:Genetics Home Reference 1062:(FAP) has been excluded 1033:(FAP) has been excluded 957:transvaginal ultrasound 308:colorectal cancer risk 4800:Dyskeratosis congenita 4541:Hepatocellular adenoma 4329:Pseudomyxoma peritonei 2688:10.17179/EXCLI2017-948 1731:10.1038/sj.onc.1202583 1336:10.1001/jama.2009.1529 707:relatively infrequent 520: 121:(second most common), 4999:Syndromes with tumors 4900:Ataxia–telangiectasia 4843:Xeroderma pigmentosum 3302:10.1056/NEJMoa2017699 3251:10.1056/NEJMoa1500596 1114:salpingo-oophorectomy 806:germline DNA mutation 514: 4954:Li–Fraumeni syndrome 4546:Cavernous hemangioma 4397:Familial adenomatous 4384:Polyposis syndromes: 1980:10.5070/D32311037239 1166:University of Oxford 837:Immunohistochemistry 832:Immunohistochemistry 822:immunohistochemistry 545:dinucleotide repeats 431:Ovarian cancer risk 255:. Increased risk of 251:, brain cancer, and 249:biliary tract cancer 4942:RAPADILINO syndrome 4877:Muir–Torre syndrome 4864:DNA mismatch repair 3940:McKay, Ami (2019). 3868:"Lynch Syndrome UK" 3793:10.1093/jnci/djh034 2105:1994Natur.371...75N 2016:1994Sci...263.1625P 1940:10.1200/EDBK_208341 1439:Williams Gynecology 1433:Hoffman BL (2012). 1379:. February 22, 2019 1217:DNA mismatch repair 922:reproductive system 592:DNA mismatch repair 579:sliding clamp model 529:DNA mismatch repair 497:6% (combined risk) 424: 253:sebaceous neoplasms 151:DNA mismatch repair 135:hepatobiliary tract 4994:Hereditary cancers 4606:Gallbladder cancer 4588:Cholangiocarcinoma 4528:Liver angiosarcoma 4462:Upper and/or lower 4411:Serrated polyposis 4116:2007-08-15 at the 4072:External resources 3404:10.3322/caac.21448 2059:10.1038/ng1197-271 1699:2006-06-19 at the 1221:Amsterdam criteria 1170:Cancer Research UK 1168:with a grant from 1008:Amsterdam criteria 961:endometrial biopsy 933:Genetic counseling 790:Amsterdam criteria 671:Papadopoulos 1994 665:approximately 30% 640:approximately 60% 615:First publication 525:autosomal dominant 521: 517:autosomal dominant 422: 289:endometrial cancer 282:. The mean age of 190:Lifetime risk (%) 168:Signs and symptoms 153:. It is a type of 119:endometrial cancer 115:autosomal dominant 4989:Colorectal cancer 4971: 4970: 4967: 4966: 4829:Cockayne syndrome 4747:Metabolic disease 4713: 4712: 4681: 4680: 4673:Pancreatoblastoma 4625:exocrine pancreas 4482: 4481: 4457: 4456: 4276: 4275: 4241:Gastric carcinoma 4106: 4105: 3951:978-0-345-80946-9 3500:on July 22, 2011. 3295:(23): 2207–2218. 2206:10.1002/gcc.20644 2156:10.1038/ng0598-17 1271:(31): 9253–9261. 1191:African Americans 918:Lynch syndrome II 778: 777: 539:specimens in the 504: 503: 420: 419: 332:brain tumor risk 284:colorectal cancer 278:, and unintended 245:pancreatic cancer 241: 240: 93: 92: 59:colorectal cancer 30:Medical condition 16:(Redirected from 5011: 4817: 4740: 4733: 4726: 4717: 4493: 4392:MUTYH-associated 4377:Cronkhite–Canada 4348:Colorectal polyp 4287: 4263:Linitis plastica 4251:Gastric lymphoma 4206: 4197: 4177: 4170: 4163: 4154: 3974: 3963: 3922: 3921: 3919: 3917: 3906: 3900: 3899: 3897: 3895: 3885: 3879: 3878: 3876: 3874: 3864: 3858: 3857: 3852:. Archived from 3821: 3815: 3814: 3804: 3772: 3766: 3765: 3733: 3727: 3726: 3716: 3684: 3678: 3677: 3667: 3635: 3629: 3628: 3618: 3586: 3580: 3579: 3543: 3537: 3536: 3508: 3502: 3501: 3496:. Archived from 3494:www.oncolink.org 3486: 3480: 3479: 3469: 3437: 3426: 3425: 3415: 3383: 3372: 3371: 3369: 3368: 3353: 3347: 3346: 3344: 3343: 3329: 3323: 3322: 3304: 3279: 3273: 3272: 3262: 3230: 3224: 3223: 3213: 3181: 3175: 3163: 3157: 3156: 3120: 3107: 3106: 3070: 3055: 3054: 3044: 3029:Gastroenterology 3020: 3014: 3013: 3003: 2963: 2952: 2951: 2949: 2948: 2933: 2920: 2919: 2909: 2899: 2875: 2869: 2868: 2832: 2823: 2822: 2812: 2780: 2771: 2765: 2759: 2758: 2740: 2716: 2710: 2709: 2699: 2673: 2664: 2658: 2657: 2647: 2637: 2613: 2602: 2601: 2591: 2580:10.3310/hta21510 2557: 2546: 2545: 2535: 2524:10.3310/hta18580 2501: 2495: 2494: 2484: 2466: 2442: 2431: 2430: 2407:Gastroenterology 2401: 2392: 2391: 2386:. Archived from 2380: 2374: 2373: 2337: 2331: 2330: 2320: 2310: 2286: 2280: 2279: 2242: 2236: 2235: 2217: 2191: 2182: 2176: 2175: 2139: 2133: 2132: 2113:10.1038/371075a0 2088: 2079: 2078: 2042: 2036: 2035: 2010:(5153): 1625–9. 1999: 1993: 1992: 1982: 1958: 1952: 1951: 1923: 1917: 1916: 1906: 1882: 1873: 1872: 1836: 1830: 1829: 1801: 1795: 1794: 1784: 1774: 1750: 1744: 1743: 1733: 1709: 1703: 1691: 1685: 1684: 1677:"Lynch Syndrome" 1673: 1667: 1666: 1618: 1612: 1611: 1601: 1576:(7): 1306–1316. 1561: 1555: 1554: 1544: 1526: 1501: 1495: 1494: 1470: 1464: 1463: 1461: 1460: 1451:. Archived from 1430: 1424: 1423: 1406:(10): 999–1017. 1395: 1389: 1388: 1386: 1384: 1373:"Lynch Syndrome" 1369: 1358: 1357: 1347: 1315: 1309: 1308: 1298: 1280: 1256: 1183:French Canadians 1116:(removal of the 1085:keratoacanthomas 959:with or without 914:Lynch syndrome I 734:Nicolaides 1994 713:Nicolaides 1994 597: 590:involved in the 425: 302: 184: 89: 88: 45: 33: 21: 5019: 5018: 5014: 5013: 5012: 5010: 5009: 5008: 4974: 4973: 4972: 4963: 4933:Werner syndrome 4909: 4886: 4854: 4806: 4763:DNA replication 4757: 4751:DNA replication 4744: 4714: 4709: 4677: 4610: 4568: 4478: 4453: 4435: 4333: 4310: 4299:Duodenal cancer 4291:Small intestine 4272: 4227: 4186: 4181: 4118:Wayback Machine 4107: 4102: 4101: 4067: 4066: 3985: 3971: 3952: 3939: 3936: 3931: 3929:Further reading 3926: 3925: 3915: 3913: 3908: 3907: 3903: 3893: 3891: 3887: 3886: 3882: 3872: 3870: 3866: 3865: 3861: 3836:(24): 4934–43. 3823: 3822: 3818: 3774: 3773: 3769: 3735: 3734: 3730: 3686: 3685: 3681: 3650:(16): 1979–85. 3637: 3636: 3632: 3588: 3587: 3583: 3545: 3544: 3540: 3510: 3509: 3505: 3488: 3487: 3483: 3446:Familial Cancer 3439: 3438: 3429: 3385: 3384: 3375: 3366: 3364: 3355: 3354: 3350: 3341: 3339: 3331: 3330: 3326: 3281: 3280: 3276: 3245:(26): 2509–20. 3232: 3231: 3227: 3190:Familial Cancer 3183: 3182: 3178: 3164: 3160: 3122: 3121: 3110: 3072: 3071: 3058: 3022: 3021: 3017: 2965: 2964: 2955: 2946: 2944: 2935: 2934: 2923: 2877: 2876: 2872: 2834: 2833: 2826: 2782: 2781: 2774: 2766: 2762: 2718: 2717: 2713: 2671: 2666: 2665: 2661: 2615: 2614: 2605: 2559: 2558: 2549: 2503: 2502: 2498: 2444: 2443: 2434: 2403: 2402: 2395: 2382: 2381: 2377: 2342:Familial Cancer 2339: 2338: 2334: 2291:"MSH6 syndrome" 2288: 2287: 2283: 2254:(11): 1539–44. 2244: 2243: 2239: 2189: 2184: 2183: 2179: 2144:Nature Genetics 2141: 2140: 2136: 2099:(6492): 75–80. 2090: 2089: 2082: 2047:Nature Genetics 2044: 2043: 2039: 2001: 2000: 1996: 1960: 1959: 1955: 1934:(38): 101–109. 1925: 1924: 1920: 1884: 1883: 1876: 1847:(9): 999–1011. 1838: 1837: 1833: 1803: 1802: 1798: 1752: 1751: 1747: 1711: 1710: 1706: 1701:Wayback Machine 1692: 1688: 1675: 1674: 1670: 1620: 1619: 1615: 1563: 1562: 1558: 1503: 1502: 1498: 1472: 1471: 1467: 1458: 1456: 1449: 1432: 1431: 1427: 1397: 1396: 1392: 1382: 1380: 1371: 1370: 1361: 1317: 1316: 1312: 1258: 1257: 1250: 1245: 1233: 1203: 1178: 1162: 1134: 1122:fallopian tubes 1106: 1010: 930: 895:adenocarcinomas 878: 853:microsatellites 849: 841:mismatch repair 834: 802: 572:DNA polymerases 509: 327:prostate cancer 257:prostate cancer 187:Type of cancer 175: 170: 155:cancer syndrome 131:small intestine 83: 31: 28: 23: 22: 15: 12: 11: 5: 5017: 5015: 5007: 5006: 5001: 4996: 4991: 4986: 4976: 4975: 4969: 4968: 4965: 4964: 4962: 4961: 4956: 4951: 4949:Fanconi anemia 4946: 4945: 4944: 4935: 4930: 4928:Bloom syndrome 4917: 4915: 4911: 4910: 4908: 4907: 4902: 4896: 4894: 4888: 4887: 4885: 4884: 4879: 4874: 4868: 4866: 4856: 4855: 4853: 4852: 4850:IBIDS syndrome 4847: 4846: 4845: 4835: 4825: 4823: 4814: 4808: 4807: 4805: 4804: 4803: 4802: 4784: 4783: 4782: 4781: 4767: 4765: 4759: 4758: 4745: 4743: 4742: 4735: 4728: 4720: 4711: 4710: 4708: 4707: 4702: 4697: 4691: 4689: 4683: 4682: 4679: 4678: 4676: 4675: 4669: 4668: 4663: 4658: 4653: 4638: 4637: 4632: 4630:Adenocarcinoma 4620: 4618: 4612: 4611: 4609: 4608: 4596: 4595: 4593:Klatskin tumor 4590: 4578: 4576: 4570: 4569: 4567: 4566: 4561: 4549: 4548: 4543: 4531: 4530: 4525: 4523:Hepatoblastoma 4520: 4519: 4518: 4501: 4499: 4490: 4484: 4483: 4480: 4479: 4477: 4476: 4471: 4465: 4463: 4459: 4458: 4455: 4454: 4452: 4451: 4445: 4443: 4437: 4436: 4434: 4433: 4428: 4423: 4421:Adenocarcinoma 4414: 4413: 4408: 4403: 4394: 4389: 4380: 4379: 4343: 4341: 4335: 4334: 4332: 4331: 4326: 4320: 4318: 4312: 4311: 4309: 4308: 4307: 4306: 4304:Adenocarcinoma 4295: 4293: 4284: 4278: 4277: 4274: 4273: 4271: 4270: 4265: 4260: 4259: 4258: 4248: 4243: 4237: 4235: 4229: 4228: 4226: 4225: 4223:Adenocarcinoma 4220: 4214: 4212: 4203: 4194: 4188: 4187: 4182: 4180: 4179: 4172: 4165: 4157: 4151: 4150: 4145: 4129: 4124: 4104: 4103: 4100: 4099: 4088: 4086:Lynch Syndrome 4076: 4075: 4073: 4069: 4068: 4065: 4064: 4053: 4042: 4025: 4006: 3986: 3981: 3980: 3978: 3977:Classification 3970: 3969:External links 3967: 3966: 3965: 3950: 3935: 3932: 3930: 3927: 3924: 3923: 3901: 3880: 3859: 3856:on 2013-04-15. 3816: 3767: 3748:(11): 1390–7. 3728: 3705:10.1086/316942 3699:(1): 118–127. 3679: 3630: 3581: 3538: 3503: 3481: 3452:(2): 211–219. 3427: 3398:(3): 217–231. 3373: 3348: 3324: 3274: 3225: 3176: 3158: 3131:(2): 299–304. 3108: 3056: 3015: 2978:(6): 812–823. 2953: 2921: 2870: 2843:(5): 512–521. 2824: 2795:(3): 411–444. 2772: 2760: 2711: 2659: 2603: 2547: 2496: 2432: 2393: 2390:on 2019-02-28. 2375: 2332: 2281: 2237: 2177: 2134: 2080: 2037: 1994: 1953: 1918: 1897:(5): 1027–38. 1874: 1831: 1796: 1745: 1724:(12): 2143–7. 1704: 1686: 1668: 1633:(5): 512–521. 1613: 1556: 1496: 1465: 1448:978-0071716727 1447: 1425: 1390: 1359: 1330:(16): 1790–5. 1310: 1247: 1246: 1244: 1241: 1232: 1229: 1206:Henry T. Lynch 1202: 1199: 1195:Ashkenazi Jews 1177: 1174: 1161: 1158: 1154: 1153: 1146:5-fluorouracil 1133: 1130: 1105: 1102: 1098: 1097: 1094: 1091: 1088: 1080: 1064: 1063: 1057: 1054: 1051: 1035: 1034: 1028: 1025: 1022: 1009: 1006: 1005: 1004: 993: 990:bladder cancer 986: 929: 926: 903: 902: 892: 889: 877: 876:Classification 874: 861:DNA extraction 848: 845: 833: 830: 808:in one of the 801: 798: 785:detecting it. 776: 775: 773: 770: 767: 760: 756: 755: 753: 750: 747: 740: 736: 735: 732: 729: 726: 719: 715: 714: 711: 708: 705: 698: 694: 693: 690: 687: 684: 677: 673: 672: 669: 666: 663: 656: 648: 647: 644: 641: 638: 625: 617: 616: 613: 610: 607: 604: 583: 582: 575: 508: 505: 502: 501: 498: 495: 487: 486: 483: 480: 472: 471: 468: 465: 451: 450: 447: 444: 436: 435: 432: 429: 418: 417: 414: 411: 408: 405: 402: 399: 396: 390: 389: 386: 383: 380: 377: 374: 371: 368: 362: 361: 358: 355: 352: 349: 346: 343: 340: 334: 333: 330: 324: 321: 318: 315:ovarian cancer 312: 309: 306: 293:gastric cancer 268:proximal colon 239: 238: 235: 232: 228: 227: 224: 221: 217: 216: 213: 210: 206: 205: 202: 199: 195: 194: 191: 188: 174: 173:Risk of cancer 171: 169: 166: 111:Lynch syndrome 91: 90: 77: 71: 70: 47: 46: 38: 37: 29: 26: 24: 14: 13: 10: 9: 6: 4: 3: 2: 5016: 5005: 5002: 5000: 4997: 4995: 4992: 4990: 4987: 4985: 4982: 4981: 4979: 4960: 4957: 4955: 4952: 4950: 4947: 4943: 4939: 4936: 4934: 4931: 4929: 4926: 4925: 4924: 4923: 4922:RecQ helicase 4919: 4918: 4916: 4912: 4906: 4903: 4901: 4898: 4897: 4895: 4893: 4889: 4883: 4880: 4878: 4875: 4873: 4870: 4869: 4867: 4865: 4861: 4857: 4851: 4848: 4844: 4841: 4840: 4839: 4838:Thymine dimer 4836: 4834: 4830: 4827: 4826: 4824: 4822: 4818: 4815: 4813: 4809: 4801: 4798: 4797: 4796: 4795: 4790: 4786: 4785: 4780: 4777: 4776: 4775: 4774: 4769: 4768: 4766: 4764: 4760: 4756: 4752: 4748: 4741: 4736: 4734: 4729: 4727: 4722: 4721: 4718: 4706: 4703: 4701: 4698: 4696: 4693: 4692: 4690: 4688: 4684: 4674: 4671: 4670: 4667: 4664: 4662: 4659: 4657: 4654: 4652: 4648: 4647: 4644: 4640: 4639: 4636: 4633: 4631: 4628: 4626: 4622: 4621: 4619: 4617: 4613: 4607: 4604: 4602: 4598: 4597: 4594: 4591: 4589: 4586: 4584: 4580: 4579: 4577: 4575: 4574:Biliary tract 4571: 4565: 4562: 4560: 4557: 4555: 4551: 4550: 4547: 4544: 4542: 4539: 4537: 4533: 4532: 4529: 4526: 4524: 4521: 4517: 4516:Fibrolamellar 4514: 4513: 4512: 4509: 4507: 4503: 4502: 4500: 4498: 4494: 4491: 4489: 4485: 4475: 4472: 4470: 4467: 4466: 4464: 4460: 4450: 4447: 4446: 4444: 4442: 4438: 4432: 4429: 4427: 4424: 4422: 4419: 4416: 4415: 4412: 4409: 4407: 4404: 4402: 4398: 4395: 4393: 4390: 4388: 4385: 4382: 4381: 4378: 4374: 4373:Peutz–Jeghers 4370: 4366: 4362: 4358: 4354: 4351: 4349: 4345: 4344: 4342: 4340: 4336: 4330: 4327: 4325: 4322: 4321: 4319: 4317: 4313: 4305: 4302: 4301: 4300: 4297: 4296: 4294: 4292: 4288: 4285: 4283: 4279: 4269: 4266: 4264: 4261: 4257: 4256:MALT lymphoma 4254: 4253: 4252: 4249: 4247: 4244: 4242: 4239: 4238: 4236: 4234: 4230: 4224: 4221: 4219: 4216: 4215: 4213: 4211: 4207: 4204: 4202: 4198: 4195: 4193: 4189: 4185: 4178: 4173: 4171: 4166: 4164: 4159: 4158: 4155: 4149: 4146: 4143: 4139: 4135: 4134: 4130: 4128: 4125: 4123: 4119: 4115: 4112: 4111:FAQs on HNPCC 4109: 4108: 4098: 4094: 4093: 4089: 4087: 4083: 4082: 4078: 4077: 4074: 4070: 4063: 4059: 4058: 4054: 4052: 4048: 4047: 4043: 4041: 4038: 4035: 4031: 4030: 4026: 4024: 4020: 4016: 4015: 4011: 4007: 4005: 4001: 3997: 3996: 3992: 3988: 3987: 3984: 3979: 3975: 3968: 3961: 3957: 3953: 3947: 3943: 3938: 3937: 3933: 3928: 3911: 3905: 3902: 3890: 3884: 3881: 3869: 3863: 3860: 3855: 3851: 3847: 3843: 3839: 3835: 3831: 3827: 3820: 3817: 3812: 3808: 3803: 3798: 3794: 3790: 3786: 3782: 3778: 3771: 3768: 3763: 3759: 3755: 3751: 3747: 3743: 3739: 3732: 3729: 3724: 3720: 3715: 3710: 3706: 3702: 3698: 3694: 3690: 3683: 3680: 3675: 3671: 3666: 3661: 3657: 3653: 3649: 3645: 3641: 3634: 3631: 3626: 3622: 3617: 3612: 3608: 3604: 3601:(4): 637–45. 3600: 3596: 3592: 3585: 3582: 3577: 3573: 3569: 3565: 3561: 3557: 3554:(6): 405–17. 3553: 3549: 3542: 3539: 3534: 3530: 3526: 3522: 3519:(2): 206–12. 3518: 3514: 3507: 3504: 3499: 3495: 3491: 3485: 3482: 3477: 3473: 3468: 3463: 3459: 3455: 3451: 3447: 3443: 3436: 3434: 3432: 3428: 3423: 3419: 3414: 3409: 3405: 3401: 3397: 3393: 3389: 3382: 3380: 3378: 3374: 3363: 3359: 3352: 3349: 3338: 3334: 3328: 3325: 3320: 3316: 3312: 3308: 3303: 3298: 3294: 3290: 3286: 3278: 3275: 3270: 3266: 3261: 3256: 3252: 3248: 3244: 3240: 3236: 3229: 3226: 3221: 3217: 3212: 3207: 3203: 3199: 3195: 3191: 3187: 3180: 3177: 3173: 3169: 3162: 3159: 3154: 3150: 3146: 3142: 3138: 3134: 3130: 3126: 3119: 3117: 3115: 3113: 3109: 3104: 3100: 3096: 3092: 3088: 3084: 3081:(4): 969–76. 3080: 3076: 3069: 3067: 3065: 3063: 3061: 3057: 3052: 3048: 3043: 3038: 3035:(6): 1453–6. 3034: 3030: 3026: 3019: 3016: 3011: 3007: 3002: 2997: 2993: 2989: 2985: 2981: 2977: 2973: 2969: 2962: 2960: 2958: 2954: 2942: 2938: 2932: 2930: 2928: 2926: 2922: 2917: 2913: 2908: 2903: 2898: 2893: 2889: 2885: 2881: 2874: 2871: 2866: 2862: 2858: 2854: 2850: 2846: 2842: 2838: 2831: 2829: 2825: 2820: 2816: 2811: 2806: 2802: 2798: 2794: 2790: 2786: 2779: 2777: 2773: 2769: 2764: 2761: 2756: 2752: 2748: 2744: 2739: 2734: 2730: 2726: 2722: 2715: 2712: 2707: 2703: 2698: 2693: 2689: 2685: 2681: 2677: 2676:EXCLI Journal 2670: 2663: 2660: 2655: 2651: 2646: 2641: 2636: 2631: 2627: 2623: 2619: 2612: 2610: 2608: 2604: 2599: 2595: 2590: 2585: 2581: 2577: 2574:(51): 1–238. 2573: 2569: 2568: 2563: 2556: 2554: 2552: 2548: 2543: 2539: 2534: 2529: 2525: 2521: 2518:(58): 1–406. 2517: 2513: 2512: 2507: 2500: 2497: 2492: 2488: 2483: 2478: 2474: 2470: 2465: 2460: 2456: 2452: 2448: 2441: 2439: 2437: 2433: 2428: 2424: 2420: 2416: 2413:(2): 502–26. 2412: 2408: 2400: 2398: 2394: 2389: 2385: 2379: 2376: 2371: 2367: 2363: 2359: 2355: 2351: 2348:(2): 141–50. 2347: 2343: 2336: 2333: 2328: 2324: 2319: 2314: 2309: 2304: 2300: 2296: 2292: 2285: 2282: 2277: 2273: 2269: 2265: 2261: 2257: 2253: 2249: 2241: 2238: 2233: 2229: 2225: 2221: 2216: 2211: 2207: 2203: 2200:(4): 340–50. 2199: 2195: 2188: 2181: 2178: 2173: 2169: 2165: 2161: 2157: 2153: 2149: 2145: 2138: 2135: 2130: 2126: 2122: 2118: 2114: 2110: 2106: 2102: 2098: 2094: 2087: 2085: 2081: 2076: 2072: 2068: 2064: 2060: 2056: 2052: 2048: 2041: 2038: 2033: 2029: 2025: 2021: 2017: 2013: 2009: 2005: 1998: 1995: 1990: 1986: 1981: 1976: 1972: 1968: 1964: 1957: 1954: 1949: 1945: 1941: 1937: 1933: 1929: 1922: 1919: 1914: 1910: 1905: 1900: 1896: 1892: 1888: 1881: 1879: 1875: 1870: 1866: 1862: 1858: 1854: 1850: 1846: 1842: 1835: 1832: 1827: 1823: 1819: 1815: 1812:(6): 1174–9. 1811: 1807: 1800: 1797: 1792: 1788: 1783: 1778: 1773: 1768: 1764: 1760: 1756: 1749: 1746: 1741: 1737: 1732: 1727: 1723: 1719: 1715: 1708: 1705: 1702: 1698: 1695: 1690: 1687: 1682: 1678: 1672: 1669: 1664: 1660: 1656: 1652: 1648: 1644: 1640: 1636: 1632: 1628: 1624: 1617: 1614: 1609: 1605: 1600: 1595: 1591: 1587: 1583: 1579: 1575: 1571: 1567: 1560: 1557: 1552: 1548: 1543: 1538: 1534: 1530: 1525: 1520: 1516: 1512: 1508: 1500: 1497: 1492: 1488: 1485:(6): 468–74. 1484: 1480: 1476: 1469: 1466: 1455:on 2014-01-04 1454: 1450: 1444: 1440: 1436: 1429: 1426: 1421: 1417: 1413: 1409: 1405: 1401: 1394: 1391: 1378: 1374: 1368: 1366: 1364: 1360: 1355: 1351: 1346: 1341: 1337: 1333: 1329: 1325: 1321: 1314: 1311: 1306: 1302: 1297: 1292: 1288: 1284: 1279: 1274: 1270: 1266: 1262: 1255: 1253: 1249: 1242: 1240: 1238: 1230: 1228: 1225: 1222: 1218: 1213: 1211: 1207: 1200: 1198: 1196: 1192: 1188: 1184: 1175: 1173: 1171: 1167: 1159: 1157: 1151: 1150: 1149: 1147: 1142: 1139: 1131: 1129: 1127: 1123: 1119: 1115: 1111: 1108:Prophylactic 1103: 1101: 1095: 1092: 1089: 1086: 1081: 1078: 1077: 1076: 1073: 1072: 1068: 1061: 1058: 1055: 1052: 1049: 1048: 1047: 1046: 1042: 1040: 1032: 1029: 1026: 1023: 1020: 1019: 1018: 1017: 1013: 1007: 1002: 998: 994: 991: 987: 984: 980: 976: 975: 974: 970: 969: 968:Other cancers 965: 962: 958: 953: 952: 948: 945: 944:Colonoscopies 941: 940: 936: 934: 927: 925: 923: 919: 915: 910: 908: 900: 896: 893: 890: 887: 886: 885: 883: 875: 873: 871: 866: 862: 858: 854: 846: 844: 842: 838: 831: 829: 827: 823: 819: 815: 811: 807: 799: 797: 793: 791: 786: 783: 774: 771: 768: 766: 765: 761: 758: 757: 754: 751: 748: 746: 745: 741: 738: 737: 733: 730: 727: 725: 724: 720: 717: 716: 712: 709: 706: 704: 703: 699: 696: 695: 691: 688: 685: 683: 682: 678: 675: 674: 670: 667: 664: 662: 661: 657: 654: 650: 649: 645: 642: 639: 637: 636: 631: 630: 626: 623: 619: 618: 614: 611: 608: 605: 602: 599: 598: 595: 593: 589: 580: 576: 573: 569: 565: 561: 560: 559: 558:to function: 557: 552: 550: 546: 542: 538: 534: 530: 526: 518: 513: 506: 499: 496: 494: 493: 489: 488: 484: 481: 479: 478: 474: 473: 469: 466: 464: 463: 458: 457: 453: 452: 448: 445: 443: 442: 438: 437: 433: 430: 427: 426: 415: 412: 409: 406: 403: 400: 397: 395: 392: 391: 387: 384: 381: 378: 375: 372: 369: 367: 364: 363: 359: 356: 353: 350: 347: 344: 341: 339: 336: 335: 331: 328: 325: 322: 319: 316: 313: 310: 307: 304: 303: 300: 297: 294: 290: 285: 281: 277: 273: 269: 264: 262: 261:breast cancer 258: 254: 250: 246: 236: 233: 230: 229: 225: 222: 219: 218: 214: 211: 208: 207: 203: 200: 197: 196: 192: 189: 186: 185: 182: 181: 180: 172: 167: 165: 163: 158: 156: 152: 148: 144: 140: 139:urinary tract 136: 132: 128: 124: 120: 116: 112: 107: 105: 101: 97: 87: 81: 78: 76: 72: 68: 67:H&E stain 64: 60: 56: 52: 48: 44: 39: 34: 19: 4920: 4871: 4792: 4787:Termination/ 4771: 4641: 4623: 4599: 4581: 4552: 4534: 4504: 4430: 4417: 4383: 4357:hyperplastic 4346: 4339:Colon/rectum 4131: 4090: 4079: 4055: 4044: 4027: 4008: 3989: 3941: 3914:. Retrieved 3912:. 2018-03-20 3904: 3892:. Retrieved 3883: 3871:. Retrieved 3862: 3854:the original 3833: 3829: 3819: 3787:(4): 261–8. 3784: 3780: 3770: 3745: 3741: 3731: 3696: 3692: 3682: 3647: 3643: 3633: 3598: 3594: 3584: 3551: 3547: 3541: 3516: 3512: 3506: 3498:the original 3493: 3484: 3449: 3445: 3395: 3391: 3365:. Retrieved 3361: 3351: 3340:. Retrieved 3336: 3327: 3292: 3288: 3277: 3242: 3238: 3228: 3196:(1): 41–52. 3193: 3189: 3179: 3161: 3128: 3124: 3078: 3074: 3032: 3028: 3018: 2975: 2971: 2945:. Retrieved 2943:. 2020-04-01 2940: 2887: 2883: 2873: 2840: 2836: 2792: 2788: 2763: 2728: 2724: 2714: 2679: 2675: 2662: 2628:(10): 1567. 2625: 2621: 2571: 2565: 2515: 2509: 2499: 2454: 2450: 2410: 2406: 2388:the original 2378: 2345: 2341: 2335: 2301:(2): 103–4. 2298: 2294: 2284: 2251: 2247: 2240: 2197: 2193: 2180: 2147: 2143: 2137: 2096: 2092: 2053:(3): 271–2. 2050: 2046: 2040: 2007: 2003: 1997: 1970: 1966: 1956: 1931: 1927: 1921: 1894: 1890: 1844: 1840: 1834: 1809: 1805: 1799: 1762: 1758: 1748: 1721: 1717: 1707: 1689: 1680: 1671: 1630: 1626: 1616: 1573: 1569: 1559: 1514: 1510: 1499: 1482: 1478: 1468: 1457:. Retrieved 1453:the original 1438: 1428: 1403: 1399: 1393: 1383:November 18, 1381:. Retrieved 1376: 1327: 1323: 1313: 1268: 1264: 1234: 1226: 1214: 1204: 1179: 1176:Epidemiology 1163: 1155: 1143: 1135: 1110:hysterectomy 1107: 1099: 1074: 1070: 1069: 1065: 1044: 1043: 1036: 1015: 1014: 1011: 971: 967: 966: 954: 950: 949: 942: 939:Colon cancer 938: 937: 931: 917: 913: 911: 904: 879: 850: 835: 803: 794: 787: 781: 780:People with 779: 762: 749:case report 742: 728:case report 721: 700: 692:Miyaki 1997 679: 658: 646:Fishel 1993 633: 627: 584: 564:DNA helicase 553: 522: 490: 475: 460: 454: 439: 393: 365: 337: 298: 276:constipation 265: 242: 209:Endometrial 178: 177: 176: 159: 110: 108: 104:colon cancer 99: 95: 94: 4892:MRN complex 4601:gallbladder 4554:hyperplasia 4081:GeneReviews 3337:www.bbc.com 2941:www.cdc.gov 2890:(7): 1874. 2731:: 136–157. 2682:: 159–168. 2150:(1): 17–8. 1517:(10): 786. 1511:Diagnostics 1201:Terminology 1039:endometrium 983:small bowel 870:immunoscore 570:(RPA), and 549:nucleobases 280:weight loss 198:Colorectal 4978:Categories 4812:DNA repair 4789:telomerase 4687:Peritoneum 4057:DiseasesDB 3960:1089450897 3490:"Oncolink" 3367:2024-09-18 3342:2024-09-18 2947:2020-12-07 2457:(3): 391. 1765:(1): 576. 1759:BMC Cancer 1459:2014-06-23 1243:References 1187:Icelanders 824:(IHC), or 51:Micrograph 4646:neoplasms 4583:bile duct 4506:malignant 4488:Accessory 4418:Neoplasm: 4401:Gardner's 4324:Carcinoid 4210:Esophagus 4144:GeneTests 4120:from the 3319:227259533 2992:0017-5749 2755:252289107 2473:2072-6694 1869:195795805 1647:1097-6868 1590:1468-3288 1533:2075-4418 1287:1007-9327 1138:colectomy 1132:Treatment 928:Screening 907:histology 800:Diagnosis 769:disputed 731:2q31-q33 651:HNPCC2 ( 620:HNPCC1 ( 594:pathway: 541:pathology 75:Specialty 4773:RNASEH2A 4616:Pancreas 4387:Juvenile 4361:juvenile 4316:Appendix 4192:GI tract 4114:Archived 4092:Orphanet 3916:31 March 3894:31 March 3873:31 March 3850:15611508 3811:14970275 3762:16253017 3723:11112663 3674:15855431 3625:19793571 3576:25600795 3568:19851131 3476:30627969 3422:29485237 3311:33264544 3269:26028255 3220:17636426 3172:31378807 3153:32833106 3145:27990589 3095:26602911 3051:10348829 3010:23408351 2916:32664613 2865:29024566 2857:28411145 2819:31780574 2747:36115290 2706:29743854 2654:31618962 2598:28895526 2542:25244061 2491:33494280 2427:25043945 2370:25479413 2362:19851887 2327:19804606 2276:10608978 2268:18625694 2232:15526044 2224:19156873 2172:46658147 2075:22473295 1989:29447627 1948:30231390 1861:31273487 1826:12637487 1791:29783979 1740:10321739 1718:Oncogene 1697:Archived 1663:29024566 1655:28411145 1608:28754778 1551:33027913 1491:26977831 1420:28891842 1354:19861671 1305:26309352 1160:Research 772:14q24.3 519:fashion. 507:Genetics 272:diarrhea 231:Ovarian 220:Gastric 137:, upper 80:Oncology 53:showing 4353:adenoma 4233:Stomach 4051:D003123 3802:2933058 3714:1234904 3665:2933042 3616:3454516 3533:5901552 3467:6450737 3413:5980692 3260:4481136 3211:2847875 3103:6014333 3001:3647358 2907:7408795 2884:Cancers 2810:7034349 2697:5938532 2645:6826728 2622:Cancers 2589:5611555 2533:4781313 2482:7864494 2451:Cancers 2318:2735474 2164:9590282 2129:4244907 2121:8072530 2101:Bibcode 2067:9354786 2032:8128251 2012:Bibcode 2004:Science 1913:8252616 1782:5963021 1599:6031262 1542:7600989 1377:DynaMed 1345:4091624 1296:4541378 1231:Society 1126:ovaries 1104:Surgery 979:stomach 759:HNPCC7 739:HNPCC6 718:HNPCC3 697:HNPCC4 676:HNPCC5 547:of the 485:16-26% 470:25-60% 449:25-60% 127:stomach 4643:cystic 4536:benign 4040:114400 4037:609310 4034:120435 3958:  3948:  3848:  3809:  3799:  3760:  3721:  3711:  3672:  3662:  3623:  3613:  3574:  3566:  3531:  3474:  3464:  3420:  3410:  3317:  3309:  3267:  3257:  3218:  3208:  3170:  3151:  3143:  3101:  3093:  3049:  3008:  2998:  2990:  2914:  2904:  2863:  2855:  2817:  2807:  2753:  2745:  2704:  2694:  2652:  2642:  2596:  2586:  2540:  2530:  2489:  2479:  2471:  2425:  2368:  2360:  2325:  2315:  2274:  2266:  2230:  2222:  2170:  2162:  2127:  2119:  2093:Nature 2073:  2065:  2030:  1987:  1973:(11). 1946:  1911:  1867:  1859:  1824:  1789:  1779:  1738:  1661:  1653:  1645:  1606:  1596:  1588:  1549:  1539:  1531:  1489:  1445:  1418:  1352:  1342:  1303:  1293:  1285:  1193:, and 1124:, and 1118:uterus 744:TGFBR2 686:7-10% 653:609310 622:120435 612:Locus 556:dimers 537:cancer 482:1-11% 467:4-24% 446:4-24% 215:48-62 212:25-60 204:44-61 201:52-58 145:, and 82:  57:(in a 4914:Other 4497:Liver 4282:Lower 4201:Upper 4133:hnpcc 4023:154.1 4019:153.0 3934:Books 3572:S2CID 3315:S2CID 3149:S2CID 3099:S2CID 2861:S2CID 2751:S2CID 2672:(PDF) 2366:S2CID 2272:S2CID 2228:S2CID 2190:(PDF) 2168:S2CID 2125:S2CID 2071:S2CID 1865:S2CID 1659:S2CID 1001:brain 901:(TIL) 814:EPCAM 752:3p22 710:7p22 689:2p16 668:3p21 643:2p22 635:EPCAM 603:name 588:genes 462:EPCAM 428:Gene 388:n.a. 329:risk 317:risk 305:Gene 237:42.5 234:4-12 223:6-13 143:brain 123:ovary 113:, an 100:HNPCC 4794:DKC1 4753:and 4441:Anus 4062:5812 4046:MeSH 4029:OMIM 4014:9-CM 3956:OCLC 3946:ISBN 3918:2018 3896:2018 3875:2018 3846:PMID 3807:PMID 3758:PMID 3719:PMID 3670:PMID 3644:JAMA 3621:PMID 3564:PMID 3529:PMID 3472:PMID 3418:PMID 3307:PMID 3265:PMID 3216:PMID 3168:PMID 3141:PMID 3091:PMID 3047:PMID 3006:PMID 2988:ISSN 2912:PMID 2853:PMID 2815:PMID 2743:PMID 2702:PMID 2650:PMID 2594:PMID 2538:PMID 2487:PMID 2469:ISSN 2423:PMID 2358:PMID 2323:PMID 2264:PMID 2220:PMID 2160:PMID 2117:PMID 2063:PMID 2028:PMID 1985:PMID 1944:PMID 1909:PMID 1891:Cell 1857:PMID 1822:PMID 1787:PMID 1736:PMID 1651:PMID 1643:ISSN 1604:PMID 1586:ISSN 1547:PMID 1529:ISSN 1487:PMID 1443:ISBN 1416:PMID 1385:2019 1350:PMID 1324:JAMA 1301:PMID 1283:ISSN 1112:and 981:and 782:MSH6 764:MLH3 723:PMS1 702:PMS2 681:MSH6 660:MLH1 629:MSH2 601:OMIM 500:15% 492:PMS2 477:MSH6 456:MSH2 441:MLH1 413:18% 410:11% 404:13% 401:46% 398:15% 394:MSH6 382:32% 379:25% 376:10% 373:17% 370:57% 366:MSH2 357:17% 351:21% 348:10% 345:43% 342:46% 338:MLH1 259:and 147:skin 4860:MSI 4138:NIH 4136:at 4097:144 4010:ICD 4004:C20 4000:C18 3991:ICD 3838:doi 3797:PMC 3789:doi 3750:doi 3746:129 3709:PMC 3701:doi 3660:PMC 3652:doi 3648:293 3611:PMC 3603:doi 3556:doi 3521:doi 3517:117 3462:PMC 3454:doi 3408:PMC 3400:doi 3297:doi 3293:383 3255:PMC 3247:doi 3243:372 3206:PMC 3198:doi 3133:doi 3083:doi 3037:doi 3033:116 2996:PMC 2980:doi 2972:Gut 2902:PMC 2892:doi 2845:doi 2841:217 2805:PMC 2797:doi 2789:Gut 2733:doi 2729:175 2692:PMC 2684:doi 2640:PMC 2630:doi 2584:PMC 2576:doi 2528:PMC 2520:doi 2477:PMC 2459:doi 2415:doi 2411:147 2350:doi 2313:PMC 2303:doi 2256:doi 2248:Gut 2210:hdl 2202:doi 2152:doi 2109:doi 2097:371 2055:doi 2020:doi 2008:263 1975:doi 1936:doi 1899:doi 1849:doi 1814:doi 1777:PMC 1767:doi 1726:doi 1635:doi 1631:217 1594:PMC 1578:doi 1570:Gut 1537:PMC 1519:doi 1408:doi 1340:PMC 1332:doi 1328:302 1291:PMC 1273:doi 924:). 865:PCR 857:MSI 810:MMR 416:1% 407:7% 385:5% 360:1% 354:8% 274:or 226:56 63:MSI 4980:: 4791:: 4749:: 4649:: 4375:, 4371:, 4367:, 4363:, 4359:, 4355:, 4142:UW 4095:: 4084:: 4060:: 4049:: 4032:: 4017:: 3998:: 3995:10 3954:. 3844:. 3834:22 3832:. 3828:. 3805:. 3795:. 3785:96 3783:. 3779:. 3756:. 3744:. 3740:. 3717:. 3707:. 3697:68 3695:. 3691:. 3668:. 3658:. 3646:. 3642:. 3619:. 3609:. 3599:18 3597:. 3593:. 3570:. 3562:. 3552:16 3550:. 3527:. 3515:. 3492:. 3470:. 3460:. 3450:18 3448:. 3444:. 3430:^ 3416:. 3406:. 3396:68 3394:. 3390:. 3376:^ 3360:. 3335:. 3313:. 3305:. 3291:. 3287:. 3263:. 3253:. 3241:. 3237:. 3214:. 3204:. 3192:. 3188:. 3147:. 3139:. 3129:62 3127:. 3111:^ 3097:. 3089:. 3079:61 3077:. 3059:^ 3045:. 3031:. 3027:. 3004:. 2994:. 2986:. 2976:62 2974:. 2970:. 2956:^ 2939:. 2924:^ 2910:. 2900:. 2888:12 2886:. 2882:. 2859:. 2851:. 2839:. 2827:^ 2813:. 2803:. 2793:69 2791:. 2787:. 2775:^ 2749:. 2741:. 2727:. 2723:. 2700:. 2690:. 2680:17 2678:. 2674:. 2648:. 2638:. 2626:11 2624:. 2620:. 2606:^ 2592:. 2582:. 2572:21 2570:. 2564:. 2550:^ 2536:. 2526:. 2516:18 2514:. 2508:. 2485:. 2475:. 2467:. 2455:13 2453:. 2449:. 2435:^ 2421:. 2409:. 2396:^ 2364:. 2356:. 2344:. 2321:. 2311:. 2297:. 2293:. 2270:. 2262:. 2252:57 2250:. 2226:. 2218:. 2208:. 2198:48 2196:. 2192:. 2166:. 2158:. 2148:19 2146:. 2123:. 2115:. 2107:. 2095:. 2083:^ 2069:. 2061:. 2051:17 2049:. 2026:. 2018:. 2006:. 1983:. 1971:23 1969:. 1965:. 1942:. 1932:38 1930:. 1907:. 1895:75 1893:. 1889:. 1877:^ 1863:. 1855:. 1845:24 1843:. 1820:. 1810:21 1808:. 1785:. 1775:. 1763:18 1761:. 1757:. 1734:. 1722:18 1720:. 1716:. 1679:. 1657:. 1649:. 1641:. 1629:. 1625:. 1602:. 1592:. 1584:. 1574:67 1572:. 1568:. 1545:. 1535:. 1527:. 1515:10 1513:. 1509:. 1483:93 1481:. 1477:. 1437:. 1414:. 1404:60 1402:. 1375:. 1362:^ 1348:. 1338:. 1326:. 1322:. 1299:. 1289:. 1281:. 1269:21 1267:. 1263:. 1251:^ 1189:, 1185:, 1120:, 955:A 655:) 624:) 566:, 157:. 141:, 133:, 129:, 125:, 106:. 4940:/ 4862:/ 4831:/ 4739:e 4732:t 4725:v 4627:: 4603:: 4585:: 4556:: 4538:: 4508:: 4399:/ 4350:: 4176:e 4169:t 4162:v 4140:/ 4021:- 4012:- 4002:- 3993:- 3983:D 3962:. 3920:. 3898:. 3877:. 3840:: 3813:. 3791:: 3764:. 3752:: 3725:. 3703:: 3676:. 3654:: 3627:. 3605:: 3578:. 3558:: 3535:. 3523:: 3478:. 3456:: 3424:. 3402:: 3370:. 3345:. 3321:. 3299:: 3271:. 3249:: 3222:. 3200:: 3194:7 3174:. 3155:. 3135:: 3105:. 3085:: 3053:. 3039:: 3012:. 2982:: 2950:. 2918:. 2894:: 2867:. 2847:: 2821:. 2799:: 2757:. 2735:: 2708:. 2686:: 2656:. 2632:: 2600:. 2578:: 2544:. 2522:: 2493:. 2461:: 2429:. 2417:: 2372:. 2352:: 2346:9 2329:. 2305:: 2299:6 2278:. 2258:: 2234:. 2212:: 2204:: 2174:. 2154:: 2131:. 2111:: 2103:: 2077:. 2057:: 2034:. 2022:: 2014:: 1991:. 1977:: 1950:. 1938:: 1915:. 1901:: 1871:. 1851:: 1828:. 1816:: 1793:. 1769:: 1742:. 1728:: 1683:. 1665:. 1637:: 1610:. 1580:: 1553:. 1521:: 1493:. 1462:. 1422:. 1410:: 1387:. 1356:. 1334:: 1307:. 1275:: 1087:) 999:( 632:/ 574:. 459:/ 98:( 69:. 20:)

Index

Hereditary non-polyposis colon cancer

Micrograph
tumor-infiltrating lymphocytes
colorectal cancer
MSI
H&E stain
Specialty
Oncology
Edit this on Wikidata
colon cancer
autosomal dominant
endometrial cancer
ovary
stomach
small intestine
hepatobiliary tract
urinary tract
brain
skin
DNA mismatch repair
cancer syndrome
polymerase proofreading-associated polyposis
pancreatic cancer
biliary tract cancer
sebaceous neoplasms
prostate cancer
breast cancer
proximal colon
diarrhea

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑